Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PI3K/AKT PATHWAY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | PI3K/AKT PATHWAY |
| Key Genes/Proteins | AKT, AMYLOID, AXL, BAX, BDNF, CLU |
| Related Diseases | ANGIOGENESIS, APOPTOSIS, cancer, CELL SURVIVAL, CERAMIDE |
graph TD
PI3K_AKT_PATHWAY["PI3K/AKT PATHWAY"]
style PI3K_AKT_PATHWAY fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
PI3K_AKT_PATHWAY -->|"mediates"| Cancer_Metabolism_Reprogrammin["Cancer Metabolism Reprogramming"]
PI3K_AKT_PATHWAY -->|"promotes"| breast_cancer_drug_resistance(breast cancer drug resistance)
PI3K_AKT_PATHWAY -->|"activates"| NRF2([NRF2])
PI3K_AKT_PATHWAY -->|"phosphorylates"| GLUT1([GLUT1])
PI3K_AKT_PATHWAY -->|"phosphorylates"| HK2["HK2"]
PI3K_AKT_PATHWAY -->|"phosphorylates"| PKM2["PKM2"]
PI3K_AKT_PATHWAY -->|"regulates"| Vascular_Barrier_Function(Vascular Barrier Function)
PI3K_AKT_PATHWAY -->|"promotes"| TNBC_cell_proliferation["TNBC cell proliferation"]
PI3K_AKT_PATHWAY -->|"causes"| Cancer_Metabolism(Cancer Metabolism)
PI3K_AKT_PATHWAY -->|"regulates"| mTORC1([mTORC1])
nomilin{"nomilin"} -.->|"inhibits"| PI3K_AKT_PATHWAY
hesperetin{"hesperetin"} -->|"activates"| PI3K_AKT_PATHWAY
SQDS{"SQDS"} -.->|"inhibits"| PI3K_AKT_PATHWAY
PI3K_Inhibitor{"PI3K Inhibitor"} -.->|"inhibits"| PI3K_AKT_PATHWAY
quinolinic_acid["quinolinic acid"] -->|"activates"| PI3K_AKT_PATHWAY
ANGPT1([ANGPT1]) -->|"activates"| PI3K_AKT_PATHWAY
TREM1["TREM1"] -->|"activates"| PI3K_AKT_PATHWAY
REEP1([REEP1]) -->|"regulates"| PI3K_AKT_PATHWAY
MYC([MYC]) -->|"regulates"| PI3K_AKT_PATHWAY
TREM2([TREM2]) -->|"activates"| PI3K_AKT_PATHWAY| Target | Relation | Type | Str |
|---|---|---|---|
| Aerobic Glycolysis | associated_with | process | 0.95 |
| Cancer | associated_with | disease | 0.95 |
| Cancer Metabolism Reprogramming | mediates | process | 0.95 |
| Aerobic Glycolysis | promotes | process | 0.95 |
| breast cancer drug resistance | promotes | phenotype | 0.95 |
| Cancer | associated_with | disease | 0.92 |
| TNBC cell proliferation | promotes | process | 0.90 |
| Cancer | drives | disease | 0.90 |
| GLUT1 | phosphorylates | gene | 0.90 |
| Cancer Metabolism | causes | phenotype | 0.90 |
| glucose metabolism | regulates | process | 0.90 |
| CANCER | implicated_in | disease | 0.90 |
| NRF2 | activates | protein | 0.90 |
| PFKFB3 | phosphorylates | gene | 0.90 |
| HER2-positive breast cancer | associated_with | disease | 0.90 |
| Cancer Metabolism | modulates | process | 0.90 |
| GLUT1 | phosphorylates | protein | 0.90 |
| Aβ-Induced Cytotoxicity | protects_against | phenotype | 0.90 |
| PKM2 | phosphorylates | gene | 0.90 |
| HK2 | phosphorylates | gene | 0.90 |
| Vascular Barrier Function | regulates | phenotype | 0.90 |
| triple negative breast cancer | upstream_of | disease | 0.88 |
| TNBC Cell Proliferation | regulates | process | 0.88 |
| mTORC1 | regulates | protein | 0.88 |
| MTOR | regulates | protein | 0.85 |
| depression | modulates | disease | 0.85 |
| FOXO | regulates | gene | 0.85 |
| MYC | regulates | protein | 0.85 |
| Neuroprotection | mediates | process | 0.85 |
| neurogenesis | regulates | process | 0.85 |
| MEF2-HDAC Axis | interacts_with | mechanism | 0.85 |
| De Novo Lipid Synthesis | modulates | process | 0.85 |
| Vascular Barrier Function | mediates | phenotype | 0.85 |
| GSK3 | regulates | gene | 0.85 |
| Pentose Phosphate Pathway | modulates | process | 0.85 |
| MYC | regulates | gene | 0.85 |
| De Novo Lipid Synthesis | modulates | process | 0.85 |
| Epithelial-Mesenchymal Transition | drives | process | 0.85 |
| MTOR | regulates | gene | 0.85 |
| MEF2 | modulates | protein | 0.85 |
| HIF-1Α | regulates | protein | 0.85 |
| Blood-Brain Barrier Integrity | regulates | pathway | 0.85 |
| Vascular Barrier Function | mediates | phenotype | 0.85 |
| Pericyte Recruitment | mediates | process | 0.85 |
| HIF1A | regulates | gene | 0.85 |
| HIF-1α | regulates | protein | 0.85 |
| Pentose Phosphate Pathway | regulates | pathway | 0.80 |
| Redox Homeostasis | modulates | process | 0.80 |
| neuroinflammation | modulates | process | 0.80 |
| coronary heart disease | causes | disease | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| nomilin | inhibits | drug | 0.95 |
| Apremilast | activates | drug | 0.95 |
| quinolinic acid | activates | metabolite | 0.90 |
| PI3K Inhibitor | inhibits | drug | 0.90 |
| PTEN | inhibits | gene | 0.90 |
| hesperetin | activates | drug | 0.90 |
| Nomilin | modulates | compound | 0.90 |
| PTEN | inhibits | gene | 0.90 |
| ANXA1 | activates | protein | 0.90 |
| PI3K | part_of | gene | 0.90 |
| SQDS | inhibits | drug | 0.90 |
| ANGPT1 | activates | protein | 0.85 |
| PDK1 | inhibits | gene | 0.85 |
| PI3K | suppresses | gene | 0.80 |
| AKT1 | part_of | gene | 0.80 |
| PI3K | interacts_with | gene | 0.80 |
| REEP1 | regulates | gene | 0.80 |
| Ferroptosis | involved_in | process | 0.75 |
| MYC | regulates | gene | 0.72 |
| TBEV infection | perturbs | process | 0.70 |
| NEURON | stabilizes | cell_type | 0.70 |
| NEURON | treats | cell_type | 0.70 |
| NEURON | inhibits | cell_type | 0.70 |
| Acupuncture | regulates | process | 0.70 |
| TREM2 | activates | protein | 0.70 |
| silibinin | inhibits | gene | 0.70 |
| PDGF | causes | gene | 0.70 |
| QKF | activates | drug | 0.70 |
| SCP-oil | activates | drug | 0.70 |
| merlin | regulates | protein | 0.70 |
| LY294002 | inhibits | drug | 0.70 |
| SYK | causes | gene | 0.70 |
| BAX | activates | gene | 0.65 |
| CLU | activates | gene | 0.65 |
| SEPSIS | regulates | disease | 0.65 |
| ASTROCYTES | activates | cell_type | 0.65 |
| METASTASIS | activates | phenotype | 0.65 |
| METASTASIS | interacts_with | phenotype | 0.65 |
| METASTASIS | regulates | phenotype | 0.65 |
| SEPSIS | treats | disease | 0.65 |
| SODIUM BUTYRATE | regulates | drug | 0.65 |
| DAP12 | activates | protein | 0.50 |
| Pi3K | associated_with | pathway | 0.50 |
| cancer | associated_with | disease | 0.50 |
| Pi3K/Akt | associated_with | pathway | 0.50 |
| Pi3K | activates | pathway | 0.50 |
| cancer | activates | disease | 0.50 |
| Pi3K/Akt | activates | pathway | 0.50 |
| Pi3K | interacts_with | pathway | 0.50 |
| Pi3K/Akt | interacts_with | pathway | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PI3K/AKT PATHWAY in their description or question text
No additional research found